Logo image of ITRM

ITERUM THERAPEUTICS PLC (ITRM) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:ITRM - IE000TTOOBX0 - Common Stock

0.3355 USD
-0.03 (-7.58%)
Last: 1/26/2026, 4:48:36 PM
0.3482 USD
+0.01 (+3.79%)
After Hours: 1/26/2026, 4:48:36 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ITRM revenue by date.ITRM revenue by date.
510K870K
70.59%
40K
-95.40%

-100.00%
3.264M9.564M
193.01%
42.172M
340.95%
49.708M
17.87%
77.684M
56.28%
163.95M
111.05%
201.85M
23.12%
240.31M
19.05%
316.98M
31.90%
EBITDA
YoY % growth
ITRM ebitda by date.ITRM ebitda by date.
-29.39M
-119.99%
-76.42M
-160.02%
-101.87M
-33.30%
-34.986M
68.63%
N/A
29.79%
N/A
-27.36%
N/A
-58.33%
N/A
58.64%
-25.602M
-36.79%
-16.524M
35.46%
25.398M
253.70%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ITRM ebit by date.ITRM ebit by date.
-29.46M
-120.51%
-76.56M
-159.88%
-102.02M
-33.25%
-35.463M
68.52%
-24.692M
23.60%
-41.231M
-23.80%
-48.998M
-54.71%
-20.606M
59.57%
-19.186M
-0.98%
-17.717M
7.65%
2.008M
111.33%
-9.704M
-583.28%
7.599M
178.31%
68.253M
798.18%
93.395M
36.84%
116.81M
25.07%
171.86M
47.13%
Operating Margin
ITRM operating margin by date.ITRM operating margin by date.
-5,776.47%-8,800.00%-255,050.00%N/AN/AN/AN/AN/A-587.80%-185.25%4.76%-19.52%9.78%41.63%46.27%48.61%54.22%
EPS
YoY % growth
ITRM eps by date.ITRM eps by date.
N/AN/A-106.65
26.89%
-37.28
63.85%
-8.72
70.04%
-3.06
80.26%
-3.01
-32.20%
-1.19
57.20%
-0.54
58.09%
-0.26
51.89%
0.11
141.18%
0.22
109.52%
1.17
422.73%
N/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.10
57.87%
-0.07
49.00%
-0.07
55.38%
-0.07
64.30%
-0.07
26.32%
Revenue
Q2Q % growth
3.065M1.428M1.965M2.41M
517.95%
3.124M
1.92%
EBITDA
Q2Q % growth
-8.262M
-144.00%
N/AN/AN/AN/A
EBIT
Q2Q % growth
428.4K
111.67%
-4.787M
-29.03%
-4.663M
15.65%
-4.854M
37.21%
-4.606M
-1,175.24%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.20
33.33%
-0.11-0.09-78.25%
Q2 2025
Q2Q % growth
-0.16
46.67%
-0.11-0.05-42.60%
Q1 2025
Q2Q % growth
-0.14
69.57%
-0.150.015.34%
Q4 2024
Q2Q % growth
-0.23
75.53%
-0.22-0.01-4.88%
Q3 2024
Q2Q % growth
-0.30 -0.20-0.10-47.06%
Q2 2024
Q2Q % growth
-0.30
68.42%
-0.460.1634.64%
Q1 2024
Q2Q % growth
-0.46
62.42%
-0.740.2837.80%
Q4 2023
Q2Q % growth
-0.94
-129.27%
-0.950.011.44%
Q3 2023
Q2Q % growth
-0.30
69.07%
-0.930.6367.68%
Q2 2023
Q2Q % growth
-0.95
-58.33%
-1.220.2722.39%
Q1 2023
Q2Q % growth

-308.00%
-1.22%
Q4 2022
Q2Q % growth
-0.41
-36.67%
-1.220.8166.50%
Q3 2022
Q2Q % growth
-0.97
-423.33%
-1.070.109.43%
Q2 2022
Q2Q % growth
-0.60
-200.00%
-1.070.4743.98%
Q1 2022
Q2Q % growth
-0.30
97.53%
-0.770.4760.78%
Q4 2021
Q2Q % growth
-0.30
92.59%
-0.610.3150.98%
Q3 2021
Q2Q % growth
0.30
103.33%
1.84-1.54-83.66%
Q2 2021
Q2Q % growth
0.60
105.00%
-0.991.59160.33%
Q1 2021
Q2Q % growth
-12.15
10.00%
-1.07-11.08-1,034.45%
Q4 2020
Q2Q % growth
-4.05 -2.96-1.09-36.92%
Q3 2020
Q2Q % growth
-9.00 -7.85-1.15-14.59%
Q2 2020
Q2Q % growth
-12.00 -12.390.393.17%
Q1 2020
Q2Q % growth
-13.50 -20.466.9634.03%
ITRM Yearly EPS VS EstimatesITRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -50 -100
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
2.737M-2.737M-100.00%
ITRM Yearly Revenue VS EstimatesITRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -46.15% 0% -21.84%
Revenue0% 7.32% 0% 14.29%